Multitarget treatments for sepsis more effective?

share Share

Sepsis is a dysregulation of the body's normal inflammatory response to injury and infection. New research from the University of Chicago suggests that efforts to combat sepsis might be more effective if they targeted multiple steps in the molecular processes that drive the illness. Researchers employed a computational model of the human immune response to infectious injury to offer an explanation as to why the current approach to drug/therapy-development is inadequate.

"This work evaluating the extent of interventions needed to control a simplified surrogate model of sepsis provides insight into the scope of the clinical challenge, and can serve as a guide on the path towards true 'precision control' of sepsis, according to the study published in PLOS Computational Biology.

People with sepsis may receive oxygen and intravenous fluids, as well as antibiotics to fight the underlying infection, but the condition kills 28 to 50 percent of affected patients. So far, drugs developed to attack the molecular processes that underpin sepsis have not shown clinical success.

For this simulation study, Chase Cockrell and Gary An, both with the Department of Surgery at UChicago, utilised a computational model of the human immune system, which they had previously developed specifically to investigate systemic inflammation. The model simulates how immune system cells and signalling molecules behave during sepsis, as well as the effects of disrupting various parts of these processes.

Using their model, the researchers showed that disrupting a single signalling process at a single point (or just a few points) in time would not be adequate to treat sepsis. This may explain why previous attempts that employed such a strategy have not been effective. Instead, the simulation showed, successful treatment would require drugs that frequently target multiple immune system processes.

The study also highlighted that a "one-size-fits-all" multitarget approach would still be inadequate, and true "precision medicine" would require a treatment to adapt itself based on each patient's individual response. The researchers concluded that computational modelling is necessary to generate the amount of data required by machine-learning algorithms to aid development of effective sepsis drugs.

"This project provides a reality check on how people are currently thinking about trying to treat sepsis at a drug-design level," Cockrell says. "It will hopefully help focus research into those areas that will actually provide a path towards effective therapy, such as high-resolution diagnostics and sampling, and realising that there is no 'one-size-fits-all' answer."

Source: PLOS
Image Credit: Pixabay

References:

Cockrell RC, An G (2018) Examining the controllability of sepsis using genetic algorithms on an agent-based model of systemic inflammation. PLoS Comput Biol (2):e1005876. https://doi.org/10.1371/journal.pcbi.1005876

Published on : Thu, 15 Feb 2018



Related Articles
This visual abstract depicts the findings of Wilmore et al., who demonstrate a role for serum IgA in protection against polymicrobial sepsis. Induction of protective concentrations of T cell dependent serum IgA requires colonization of the gut with a comp

New research published online in the journal Cell Host & Microbe suggests that gut bacteria may help in the fight against sepsis,... Read more

Richard Hotchkiss, MD, a professor of anesthesiology (left), and Jane Blood (right), a nurse manager in the Department of Anesthesiology's Division of Clinical and Translational Research, talk with Greg Porter, 34, of Nashville, Ill., who has recovered fr

People especially those with critical illness develop sepsis when an infection triggers an overwhelming immune response, ultimately... Read more

Sepsis can cause both brain dysfunction and neuroinflammation. New research from the University of Michigan indicates that gut... Read more

Sepsis, Multitarget treatments, infectious injury, precision control of sepsis Sepsis is a dysregulation of the body's normal inflammatory response to injury and infection. New research from the University of Chicago suggests that efforts to combat sepsis might be more effective if they targeted multiple steps in the molecular proce

No comment


Please login to leave a comment...

Highlighted Products